Susan Sam, MD, MSc, is an adult endocrinologist who specializes in the diagnosis and treatment of polycystic ovary syndrome (PCOS). She also has a clinical interest in other reproductive disorders leading to menstrual irregularity in women, type 2 diabetes and related metabolic disorders.
Dr. Sam's research focuses on the metabolic abnormalities associated with PCOS such as the high risk for development of type 2 diabetes, lipid disorders, and obesity. In particular, she examines how abnormalities in fat tissue, such as inflammation, lead to development of insulin resistance in PCOS. She has received prestigious research grants and has published her findings in a number of scientific journals, including Proceedings of the National Academy of Sciences, Diabetes, Diabetes Care, and the Journal of Clinical Endocrinology and Metabolism.
Dr. Sam serves as a manuscript reviewer for scientific journals such as Clinical Endocrinology, Obesity and Fertility and Sterility, in addition to sitting on the editorial board for the Journal of Clinical Endocrinology and Metabolism. Dr. Sam is also a teacher and mentor to medical students, residents and endocrinology fellows.
Weight loss and ß-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial.
Weight loss and ß-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial. Obesity (Silver Spring). 2022 08; 30(8):1579-1588.
PMID: 35894078
Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes.
Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes. JAMA. 2022 07 26; 328(4):389-390.
PMID: 35816353
Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.
Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study. Diabetes Care. 2021 09; 44(9):1938-1947.
PMID: 34131048
Obstructive Sleep Apnea, Glucose Tolerance, and ß-Cell Function in Adults With Prediabetes or Untreated Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.
Obstructive Sleep Apnea, Glucose Tolerance, and ß-Cell Function in Adults With Prediabetes or Untreated Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study. Diabetes Care. 2021 04; 44(4):993-1001.
PMID: 33547205
Role of obstructive sleep apnea in metabolic risk in PCOS.
Role of obstructive sleep apnea in metabolic risk in PCOS. Curr Opin Endocr Metab Res. 2021 Apr; 17:46-51.
PMID: 34368492
The association of sleep disturbances with glycemia and obesity in youth at risk for or with recently diagnosed type 2 diabetes.
The association of sleep disturbances with glycemia and obesity in youth at risk for or with recently diagnosed type 2 diabetes. Pediatr Diabetes. 2019 12; 20(8):1056-1063.
PMID: 31486162
Pathogenesis and Consequences of Disordered Sleep in PCOS.
Pathogenesis and Consequences of Disordered Sleep in PCOS. Clin Med Insights Reprod Health. 2019; 13:1179558119871269.
PMID: 31516314
Association of Self-Reported Sleep and Circadian Measures With Glycemia in Adults With Prediabetes or Recently Diagnosed Untreated Type 2 Diabetes.
Association of Self-Reported Sleep and Circadian Measures With Glycemia in Adults With Prediabetes or Recently Diagnosed Untreated Type 2 Diabetes. Diabetes Care. 2019 07; 42(7):1326-1332.
PMID: 31048411
Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones.
Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones. Physiol Rep. 2019 05; 7(10):e14111.
PMID: 31134746
Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk.
Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk. Horm Mol Biol Clin Investig. 2018 Mar 09; 33(1).
PMID: 29522417